Observational Prospective Study Describing the Global Patient Care and Follow-up of Prostate Cancer Patients Treated With Degarelix
Clinical trial NCT03193645 · COMPLETED
Trial details
- NCT number
- NCT03193645
- Sponsor
- Ferring Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2017-06-27
- Primary completion
- 2018-06-30
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.